Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001437749-24-002315
Filing Date
2024-01-26
Accepted
2024-01-26 17:27:41
Documents
1
Effectiveness Date
2024-01-26

Document Format Files

Seq Description Document Type Size
1 FORM S-8 POS navb20240126f_s8pos.htm S-8 POS 32681
  Complete submission text file 0001437749-24-002315.txt   33858
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-198716 | Film No.: 24569281
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)